P

Inventor

SMALLHEER JOANNE M

US34 patents
⚠️ This page may combine multiple inventors who share the name “SMALLHEER JOANNE M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

24 patents
US7129264B2Oct 31, 2006

Biarylmethyl indolines and indoles as antithromboembolic agents

BRISTOL MYERS SQUIBB CO88 citations97
US7626039B2Dec 1, 2009

Arylpropionamide, arylacrylamide, ayrlpropynamide, or arylmethylurea analogs as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO14 citations92
US7459564B2Dec 2, 2008

Substituted biaryl compounds as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO26 citations92
US7453002B2Nov 18, 2008

Five-membered heterocycles useful as serine protease inhibitors

BRISTOL MYERS SQUIBB CO24 citations92
US7417063B2Aug 26, 2008

Bicyclic heterocycles useful as serine protease inhibitors

BRISTOL MYERS SQUIBB CO27 citations92
US7157470B2Jan 2, 2007

Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors

BRISTOL MYERS SQUIBB CO24 citations92
US7429604B2Sep 30, 2008

Six-membered heterocycles useful as serine protease inhibitors

BRISTOL MYERS SQUIBB CO35 citations90
US10487086B2Nov 26, 2019

Macrocycles as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO3 citations84
US9802939B2Oct 31, 2017

Macrocycles as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO3 citations84
US7645799B2Jan 12, 2010

Substituted biaryl compounds as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO7 citations74
US11136327B2Oct 5, 2021

Macrocycles as factor XIA inhibitors

BRISTOL MYERS SQUIBB CO1 citations73
US10214527B2Feb 26, 2019

Triazolopyridine inhibitors of myeloperoxidase

BRISTOL MYERS SQUIBB CO2 citations71
US12404274B2Sep 2, 2025

Macrocycles as factor xia inhibitors

BRISTOL MYERS SQUIBB CO0 citations62
US7842708B2Nov 30, 2010

Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO4 citations62
US10407422B2Sep 10, 2019

Triazolopyridine inhibitors of myeloperoxidase

BRISTOL MYERS SQUIBB CO1 citations60
US10112936B2Oct 30, 2018

Five-membered heterocycles useful as serine protease inhibitors

BRISTOL MYERS SQUIBB CO0 citations51
US9617224B2Apr 11, 2017

Five-membered heterocycles useful as serine protease inhibitors

BRISTOL MYERS SQUIBB CO0 citations51
US9079860B2Jul 14, 2015

Five-membered heterocycles useful as serine protease inhibitors

BRISTOL MYERS SQUIBB CO0 citations51
US7524863B2Apr 28, 2009

Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors

BRISTOL MYERS SQUIBB CO1 citations51
US12577206B2Mar 17, 2026

Pyrazolone formyl peptide 2 receptor agonists

BRISTOL MYERS SQUIBB CO0 citations50
US11180490B2Nov 23, 2021

Cyclopropyl urea formyl peptide 2 receptor and formyl peptide 1 receptor agonists

BRISTOL MYERS SQUIBB CO0 citations50
US11008317B2May 18, 2021

Triazolopyridine inhibitors of myeloperoxidase and/or EPX

BRISTOL MYERS SQUIBB CO0 citations49
US11059818B2Jul 13, 2021

Triazolopyridine inhibitors of myeloperoxidase

BRISTOL MYERS SQUIBB CO0 citations47
US10577383B2Mar 3, 2020

Macrocyclic inhibitors of myeloperoxidase

BRISTOL MYERS SQUIBB CO0 citations39

BRISTOL MYERS SQUIBB PHARMA CO

3 patents

HANGELAND JON J

2 patents

PINTO DONALD J P

2 patents

CORTE JAMES R

1 patent

DU PONT MERCK PHARMA

1 patent

DU PONT PHARM CO

1 patent